The nonselective adenosine antagonist theophylline does prevent renal dysfunction induced by radiographic contrast agents

Journal of Nephrology

Volumn 11, Issue 3, 1998, Pages 151-156

  Kolonko, Aureliusz ^a   Wiecek, Andrzej ^a   Kokot, Franciszek ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

2 microglobulin; Erythropoietin; Plasma renin activity; Radiographic contrast agents; Tamm Horsfall protein; Theophylline; Tubular damage

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; AMINOPHYLLINUM; BETA 2 MICROGLOBULIN; CONTRAST MEDIUM; ERYTHROPOIETIN; MEGLUMINE DIATRIZOATE PLUS SODIUM DIATRIZOATE; TAMM HORSFALL GLYCOPROTEIN; THEOPHYLLINE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PLASMA RENIN ACTIVITY; PROTEINURIA; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; URINALYSIS;

ADENOSINE; ADULT; CONTRAST MEDIA; ERYTHROPOIETIN; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; OSMOLAR CONCENTRATION; PREMEDICATION; RECEPTORS, PURINERGIC P1; RENIN; THEOPHYLLINE;

EID: 0031863192     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125-37.
2. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Roentgen 1991; 157: 49-58.
3. Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropatliy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615-20.
4. Mudge GH. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 1980; 18: 540-52.
5. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast-material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320: 143-9.
6. Barrett GL, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low- osmolality iodinated contrast media. Radiology 1993; 188: 171-8.
7. Nicot GS, Merle LJ, Charmes JP, et al. Transient glomerular proteinuria, enzymuria and nephrotoxic reaction induced by radiocontrast media. J Am Med Assoc 1984; 252: 2432-4.
8. Tschakert H, Matern-Pinzek R, Schaffeldt J. Anstieg von Nierenenzymen in Harn nach Kontrastmittelgabe: Vergleich der Nephrotoxizität ionischer und nichtionischer Präparate. Aktuelle Radiol 1995; 5: 152-6.
9. Bakris GL, Gaber AO, Jones JD. Oxygen free radicals involvement in urinary Tamm-Horsfall protein excretion after intrarenal injection of contrast medium. Radiology 1990; 175: 57-60.
10. Fukui J, Yasumoto R, Kishimoto T, et al. Study on free enzymes and proteins in the urine. (abstract) Hinyokika Kiyo 1994; 40: 549-53.
11. Idee J-M, Beaufils H, Bonnemain B. Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. (abstract) Fundam Clin Pharmacol 1994; 8: 193-206.
12. Arend LJ, Bakris GL, Burnett JCJ, Megerian C, Spielman WS. Role for intrarenal adenosine in the renal hemodynamic response to contrast media. J Lab Clin Med 1987; 110: 406-11.
13. Deray G, Martinez F, Cacoub P, Baumelou B, Baumelou A, Jacobs C. A role for adenosine, calcium and ischaemia in radiocontrast-induced intrarenal vasoconstriction. Am J Nephrol 1990; 10: 316-22.
14. Dinour D, Agmon Y, Brezis M. Adenosine: an emerging role in the control of renal medullary oxygenation? Exp Nephrol 1993; 1: 153-7.
15. Spielman WS, Thompson CI. A proposed role for adenosine in the regulation of renal hemodynamics and renin release. AmJ Physiol 1982; 242: F423-35.
16. Spielman WS, Arend LJ. Adenosine receptors and signaling in the kidney. Hypertension 1991; 17: 117-30.
17. Osswald H, Gleiter C, Mühlbauer B. Therapeutic use of theophylline to antagonize renal effects of adenosine. Clin Nephrol 1995; 43 (Suppl. 1): S33-7.
18. 2 receptor. J Pharmacol Exp Ther 1991; 257: 1013-9.
19. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int 1994; 45: 1425-31.
20. Larson TS, Hudson K, Mertz JI, Romero JC, Knox FG. Renal vasoconstrictive response to contrast medium. The role of sodium balance and the renin-angiotensin system. J Lab Clin Med 1983; 101: 385-91.
21. Bohle A, Christensen J, Kokot F, et al. Acute renal failure in man: new aspects concerning pathogenesis. Am J Nephrol 1990; 10: 374-88.
22. Kokot F, Wiecek A, Grzeszczak W. Plasma parathyroid hormone and erythropoietin levels in patients wilh noninflammatory acute renal failure. Int Urol Nephrol 1993; 25: 89-96.
23. Nowicki M. Erythropoietin and hypertension. J Hum Hypertens 1995; 9: 81-8.
24. Bachmann S, LeHir M, Eckardt K-U. Colocalisation of erythropoietin and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993; 41: 335-41.
25. Maxwell PH, Ferguson DJP, Nicholls LG, et al. Sites of erythropoietin production. Kidney Int 1997; 51: 393-401.
26. 2 adenosine receptor regulation of erythropoietin secretion. Life Sci 1988; 43: 229-37.
27. Paul P, Rothmann SA, Meagher RC. Modulation of erythropoietin production by adenosine. J Lab Clin Med 1988; 112: 168-73.
28. Wiecek A, Kokot F, Kuczera M, Grzeszczak W, Kiersztejn M. Plasma erythropoietin concentration in renal venous blood of patients with unilateral renovascular hypertension. Nephrol Dial Tranplant 1992; 7: 221-4.
29. Kokot F, Kuska J, Chorazy M. Verhalten der Plasmareninaktivität und des Aldosterons nach Kochsalzbeschränkung und aufrechter Körperhaltung bei essentieller Hypertonie. Z Gesamte Inn Med 1976; 31: 1015-20.
30. Dulawa J, Drab M, Drobisz M, Kokot F. Die Ausscheidung des Tamm-Horsfall-Proteins im Urin bei Gesunden und Nierenkranken. Nieren-Hochdruckkr 1993; 22: 110-3.
31. Osswald H, Schmitz HJ, Heidenreich O. Adenosine response of the rat kidney after saline loading, sodium restriction and haemorrhagia. Pflügers Arch 1975; 357: 323-33.
32. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416-20.
33. Osswald H, Schmitz HJ, Kemper R. Renal actions of adenosine: Effect on renin secretion in the rat. Naunyn Schmiedebergs Arch Pharmacol 1978; 303: 95-9.
34. Osswald H, Hermes H, Nabakowski G. The role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int 1982; 22 (Suppl. 12): S136-42.
35. Churchill PC, Bidani AK. Renal effects of selective adenosine receptor agonist. AmJ Physiol 1987; 252: F299-F303.
36. 2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices. J Pharmacol Exp Ther 1985; 232: 589-94.
37. Barchowsky A, Data JL, Whorton AR. Inhibilion of renin release by analogues of adenosine in rabbit renal cortical slices. Hypertension 1987; 9: 619-23.
38. Arend LJ, Haramati A, Thompson CI, Spielman WS. Adenosine-induced decrease in renin release. Dissociation from hemodynamic effects. Am J Physiol 1984; 247: F447-52.
39. Arend LJ, Thompson CI, Brandt MA, Spielman WS. Elevation of intrarenal adenosine by maleic acid decreases GFR and renin release. Kidney Int 1986; 30: 656-61.
40. Itoh S, Carretero OA, Murray RD. Possible role of adenosine in the macula densa mechanism of renin release in rabbits. J Clin Invest 1985; 76: 1412-7.
41. Bakris GL, Sauter ER, Hussey JL, Fisher JW, Gaber AO, Winsett R. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation. N Engl J Med 1990; 323: 86-90.
42. Grekas D, Dioudis C, Valkouma D, Papoulidou F, Tourkantonis A. Theophylline modulates erythrocytosis after renal transplantation. Nephron 1995; 70: 25-7.
43. Ueno M, Brooking J, Beckman B, Fisher JW. Adenosine receptor regulation of erythropoietin secretion. (abstract) Kidney Int 1987; 31: 290.
44. Epstein FH. Oxygen and renal metabolism. Kidney Int 1997; 51: 381-5.
45. Dulawa J, Kokot M, Nowicki M, Kochariska A, Kokot F. Estimation of renal tubular function after Uropoline administration in patients with renal diseases. Przegl Lek 1992; 49: 362-4.
46. Sugaya K, Nishizawa O, Noto O, et al. Comparative study on nephrotoxicity of ionic and non-ionic contrast agents for drip infused urography. (abstract) Hinyokika Kiyo 1992; 38: 676-773.
47. Carraro M, Moncini W, Artero M, et al. Dose effect of nitrendipine on urinary enzymes and microproteins following nonionic radiocontrast administration. Nephrol Dial Transplant 1996; 11: 444-8.
48. Jakobsen JA, Kolbenstvedt AN, Berg KJ. Renal effects of iopentol and iohexol after intravenous injection. Acta Radiol 1991; 32: 320-4.
49. Apelqvist J, Torffvit O, Agardh CD. The effect of the non-ionic contrast medium iohexol on glomerular and tubular function in diabetic patients. Diabet Med 1996; 13: 487-92.
50. Margulies KB, McKinley LJ, Allgren RL, Stansos AW, Burnett JC Jr. Intraarterial atrial natriuretic factor (ANF) attenuates radiocontrast-induced nephropathy in humans. (abstract) J Am Soc Nephrol 1991; 2: 666.
51. Erley CM, Burgert K, Langanke J, Osswald H, Risler T. Kontrastmittel-induzierte Abnahme der GFR-Nephroprotektion durch Adenosinantagonisten. Nieren- Hochdruckkr 1995; 9: 459-60.